Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$145.74 +3.7%	$180.70	$127.70 ▼ $262.87	$10.18B	1.61	2.37 million shs	1.81 million shs
EW Edwards Lifesciences	$77.69 +1.0%	$77.10	$64.00 ▼ $83.00	$45.17B	1.08	5.02 million shs	3.48 million shs
SNN Smith & Nephew SNATS	$36.79 +1.5%	$31.00	$23.69 ▼ $36.84	$15.87B	0.68	1.03 million shs	438,295 shs
STE STERIS	$247.44 +1.5%	$234.24	$200.98 ▼ $252.79	$24.01B	0.92	697,938 shs	455,177 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	+4.21%	+0.60%	-30.55%	-25.13%	-34.22%
EW Edwards Lifesciences	-1.64%	-2.86%	-1.43%	-0.12%	+17.39%
SNN Smith & Nephew SNATS	+0.66%	+1.97%	+19.51%	+29.24%	+23.00%
STE STERIS	+0.86%	+8.85%	+6.93%	+7.46%	+4.18%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.9729 of 5 stars	4.3	4.0	0.0	3.8	3.9	3.3	2.5
EW Edwards Lifesciences	4.8227 of 5 stars	3.3	4.0	0.0	4.0	3.3	2.5	2.5
SNN Smith & Nephew SNATS	2.295 of 5 stars	1.0	3.0	2.5	0.0	2.7	0.0	3.1
STE STERIS	4.8036 of 5 stars	3.4	3.0	3.3	3.8	3.2	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.60	Moderate Buy	$215.00	47.52% Upside
EW Edwards Lifesciences	2.65	Moderate Buy	$85.90	10.57% Upside
SNN Smith & Nephew SNATS	2.00	Hold	$28.00	-23.89% Downside
STE STERIS	2.75	Moderate Buy	$273.50	10.53% Upside

Current Analyst Ratings Breakdown

Latest STE, EW, ALGN, and SNN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	STE STERIS	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$276.00 ➝ $295.00
8/7/2025	EW Edwards Lifesciences	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$84.00 ➝ $88.00
7/31/2025	ALGN Align Technology	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$210.00
7/31/2025	ALGN Align Technology	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$246.00 ➝ $199.00
7/31/2025	ALGN Align Technology	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$275.00 ➝ $200.00
7/31/2025	ALGN Align Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$250.00 ➝ $190.00
7/31/2025	ALGN Align Technology	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$249.00 ➝ $154.00
7/29/2025	EW Edwards Lifesciences	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/29/2025	EW Edwards Lifesciences	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00
7/25/2025	EW Edwards Lifesciences	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/25/2025	EW Edwards Lifesciences	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$3.96B	2.66	$9.32 per share	15.63	$53.98 per share	2.70
EW Edwards Lifesciences	$5.44B	8.39	$2.76 per share	28.17	$18.07 per share	4.30
SNN Smith & Nephew SNATS	$5.81B	2.77	$3.20 per share	11.48	$12.64 per share	2.91
STE STERIS	$5.46B	4.46	$14.47 per share	17.10	$70.77 per share	3.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.93	24.58	16.28	1.58	11.04%	13.36%	8.32%	10/22/2025 (Estimated)
EW Edwards Lifesciences	$4.17B	$6.95	11.18	28.25	3.71	72.96%	15.01%	11.56%	10/23/2025 (Estimated)
SNN Smith & Nephew SNATS	$412M	$2.16	17.03	18.40	1.11	N/A	N/A	N/A	N/A
STE STERIS	$614.64M	$6.53	37.89	24.92	N/A	11.61%	14.17%	9.25%	N/A

Latest STE, EW, ALGN, and SNN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q1 2026	STE STERIS	$2.32	$2.34	+$0.02	$1.79	$1.36 billion	$1.40 billion
7/30/2025	Q2 2025	ALGN Align Technology	$2.57	$2.49	-$0.08	$1.72	$1.06 billion	$1.01 billion
7/24/2025	Q2 2025	EW Edwards Lifesciences	$0.62	$0.67	+$0.05	$0.56	$1.49 billion	$1.53 billion
5/14/2025	Q4 2025	STE STERIS	$2.59	$2.74	+$0.15	$1.47	$1.47 billion	$1.48 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
SNN Smith & Nephew SNATS	$0.89	2.42%	N/A	41.20%	N/A
STE STERIS	$2.28	0.92%	N/A	34.92%	20 Years

Latest STE, EW, ALGN, and SNN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/6/2025	SNN Smith & Nephew SNATS	semi-annual	$0.2850	2.1%	10/3/2025	10/3/2025	11/7/2025
7/30/2025	STE STERIS	quarterly	$0.63	1.1%	9/4/2025	9/4/2025	9/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.23	1.10
EW Edwards Lifesciences	0.06	4.68	3.87
SNN Smith & Nephew SNATS	0.60	3.00	1.40
STE STERIS	0.27	2.22	1.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
EW Edwards Lifesciences	79.46%
SNN Smith & Nephew SNATS	25.64%
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.66%
EW Edwards Lifesciences	1.29%
SNN Smith & Nephew SNATS	1.00%
STE STERIS	1.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	20,945	72.49 million	72.01 million	Optionable
EW Edwards Lifesciences	15,800	587.10 million	579.53 million	Optionable
SNN Smith & Nephew SNATS	17,349	437.98 million	433.60 million	Optionable
STE STERIS	17,787	98.49 million	97.44 million	Optionable

STE, EW, ALGN, and SNN Headlines

Recent News About These Companies

STERIS plc (NYSE:STE) Director Cynthia L. Feldmann Sells 3,495 Shares

August 13 at 5:40 AM | insidertrades.com

Mizuho Securities USA LLC Sells 1,488 Shares of STERIS plc (NYSE:STE)

August 13 at 4:49 AM | marketbeat.com

National Bank of Canada FI Boosts Position in STERIS plc (NYSE:STE)

August 13 at 4:14 AM | marketbeat.com

STERIS (NYSE:STE) Stock Price Expected to Rise, Morgan Stanley Analyst Says

August 12 at 1:50 PM | marketbeat.com

Deutsche Bank AG Purchases 32,549 Shares of STERIS plc (NYSE:STE)

August 12 at 4:14 AM | marketbeat.com

Charles Schwab Investment Management Inc. Boosts Stock Holdings in STERIS plc (NYSE:STE)

August 12 at 4:13 AM | marketbeat.com

STERIS (NYSE:STE) Upgraded to "Strong-Buy" at Wall Street Zen

August 12 at 2:55 AM | americanbankingnews.com

Here's Why Steris (STE) is a Strong Growth Stock

August 11 at 10:46 AM | zacks.com

Understanding Steris (STE) Reliance on International Revenue

August 11 at 10:16 AM | zacks.com

Townsquare Capital LLC Increases Stock Position in STERIS plc (NYSE:STE)

August 11 at 6:38 AM | marketbeat.com

Forsta AP Fonden Purchases 3,000 Shares of STERIS plc (NYSE:STE)

August 11 at 6:22 AM | marketbeat.com

ASR Vermogensbeheer N.V. Purchases Shares of 4,262 STERIS plc (NYSE:STE)

August 11 at 5:56 AM | marketbeat.com

LPL Financial LLC Raises Holdings in STERIS plc (NYSE:STE)

August 11 at 5:34 AM | marketbeat.com

Fiduciary Family Office LLC Purchases Shares of 2,844 STERIS plc (NYSE:STE)

August 10 at 7:34 AM | marketbeat.com

Benjamin Edwards Inc. Acquires 20,142 Shares of STERIS plc (NYSE:STE)

August 10 at 7:10 AM | marketbeat.com

STERIS plc (NYSE:STE) Stock Position Raised by Vanguard Group Inc.

August 10 at 4:36 AM | marketbeat.com

Wealthspire Advisors LLC Makes New $272,000 Investment in STERIS plc (NYSE:STE)

August 10 at 4:29 AM | marketbeat.com

KeyBanc’s Positive View on STERIS (STE) Driven by MedTech Momentum

August 10 at 2:50 AM | finance.yahoo.com

STERIS (NYSE:STE) Upgraded to Strong-Buy at Wall Street Zen

August 10 at 2:43 AM | marketbeat.com

STERIS plc (STE) Q1 2026 Earnings Call Transcript - Seeking Alpha

August 9, 2025 | seekingalpha.com

Steris anticipates 8–9% reported revenue growth in fiscal 2026 as ...

August 9, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

STE, EW, ALGN, and SNN Company Descriptions

Align Technology NASDAQ:ALGN

$145.74 +5.25 (+3.74%)

Closing price 04:00 PM Eastern

Extended Trading

$145.93 +0.19 (+0.13%)

As of 07:55 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Edwards Lifesciences NYSE:EW

$77.69 +0.76 (+0.99%)

Closing price 03:59 PM Eastern

Extended Trading

$77.50 -0.19 (-0.24%)

As of 06:21 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Smith & Nephew SNATS NYSE:SNN

$36.79 +0.56 (+1.55%)

Closing price 03:59 PM Eastern

Extended Trading

$36.85 +0.06 (+0.18%)

As of 06:41 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

STERIS NYSE:STE

$247.44 +3.68 (+1.51%)

Closing price 03:59 PM Eastern

Extended Trading

$247.13 -0.31 (-0.13%)

As of 04:20 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time